Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)

ClinicalTrials.gov ID: NCT01772472

Public ClinicalTrials.gov record NCT01772472. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 2:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Open-Label Phase III Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy for Patients With HER2-Positive Primary Breast Cancer Who Have Residual Tumor Present Pathologically in the Breast or Axillary Lymph Nodes Following Preoperative Therapy

Study identification

NCT ID
NCT01772472
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,486 participants

Conditions and interventions

Conditions

Interventions

  • trastuzumab Drug
  • trastuzumab emtansine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2, 2013
Primary completion
Jul 24, 2018
Completion
May 22, 2024
Last update posted
Jul 21, 2025

2013 – 2024

United States locations

U.S. sites
60
U.S. states
27
U.S. cities
52
Facility City State ZIP Site status
Providence Alaska Medical Center Anchorage Alaska 99508
Todd Cancer Institute at Long Beach Memorial Medical Center Long Beach California 90806
Chao Family Comprehensive Cancer Center Orange California 92868
Stanford University Medical Center Palo Alto California 94304
Kaiser Permanente - San Diego San Diego California 92120
Breastlink Medical Group Inc Santa Ana California 92705
Kaiser Permanente - Vallejo Vallejo California 94589
Kaiser Permanente - Franklin Denver Colorado 80205
Colorado Cancer Research Program/Admin Denver Colorado 80222
Yale Cancer Center New Haven Connecticut 06510-3221
Washington Cancer Institute Washington D.C. District of Columbia 20010
University of Florida Gainesville Florida 32610
Mount Sinai Medical Center Miami Beach Florida 33140
UF Health Orlando Orlando Florida 32806
Moffitt Cancer Center Tampa Florida 33612-9497
Rush University Medical Center Chicago Illinois 60612
Edward Cancer Center Naperville Naperville Illinois 60540
Edward Cancer Center Plainfield Plainfield Illinois 60585
University of Iowa Iowa City Iowa 52242
University of Kentucky Medical Center Lexington Kentucky 40536
Norton Healthcare Inc. Louisville Kentucky 40202
Cancer Care of Maine Brewer Maine 04412
New England Cancer Specialists Scarborough Maine 04074
Mercy Medical Center Baltimore Maryland 21202
Greater Baltimore Medical Center Baltimore Maryland 21204
Med Star Franklin Square Medical Center/Weinburg Cancer Institute Baltimore Maryland 21237
Karmanos Cancer Institute Detroit Michigan 48201
Henry Ford Health System Detroit Michigan 48202
Spectrum Health Hospitals Grand Rapids Michigan 49503
Breslin Cancer Center Lansing Michigan 48910
William Beaumont Hospital Royal Oak Michigan 48073
US oncology research at Minnesota Oncology Saint Louis Park Minnesota 55426
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903
Sparta Cancer Center Sparta New Jersey 07871-1791
Columbia University Medical Center New York New York 10032
Troy Cancer Treatment Program Troy New York 12180
Carolinas Medical Center Charlotte North Carolina 28204-2839
Sanford Roger Maris Cancer Center Fargo North Dakota 58122-9988
Aultman Hospital Canton Ohio 44710
Fairview Hospital Cleveland Ohio 44111
The Cleveland Clinic Foundation Cleveland Ohio 44195
Ohio State University, Arthur James Cancer Hospital Columbus Ohio 43210
Columbia River Oncology Program Portland Oregon 97225
Kimmel Cancer Center Thomas Jefferson University Philadelphia Pennsylvania 19107
Allegheny Cancer Center Pittsburgh Pennsylvania 15212
Uni of Pittsburgh Pittsburgh Pennsylvania 15213
York Hospital York Pennsylvania 17403
Medical University of South Carolina Charleston South Carolina 29425
Avera Cancer Institute Sioux Falls South Dakota 57105
Thompson Cancer Survival Center Knoxville Tennessee 37916-2305
Baylor College of Medicine Houston Texas 77030
Houston Methodist Hospital Outpatient Center Houston Texas 77030
Uni of Texas - Md Anderson Cancer Center Houston Texas 77030
Joe Arrington Cancer Research & Treatment Center Lubbock Texas 79410
Hematology Oncology Associates of Fredericksburg, Inc. Fredericksburg Virginia 22408
Centra Alan B. Pearson Regional Cancer Center Lynchburg Virginia 24501
Virginia Commonwealth University - Massey Cancer Center Richmond Virginia 23298
Swedish Cancer Institute - Issaquah Issaquah Washington 98029
Cancer Care Northwest Spokane Washington 99204
Marshfield Clinic Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 208 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01772472, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 21, 2025 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01772472 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →